NCT07316686
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07316686
Title Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma (Lutécio)
Acronym Lutecio
Recruitment Not yet recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Instituto do Cancer do Estado de São Paulo
Indications
Therapies
Age Groups: adult | senior
Covered Countries BRA

Facility Status City State Zip Country Details
Instituto do Câncer do Estado de São Paulo - ICESP São Paulo São Paulo 01246000 Brazil Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field